Literature DB >> 30142414

Strategies for controlling CRISPR/Cas9 off-target effects and biological variations in mammalian genome editing experiments.

Michelle L Kimberland1, Wangfang Hou1, Adolfo Alfonso-Pecchio1, Stephen Wilson2, Yanhua Rao1, Shu Zhang1, Quinn Lu3.   

Abstract

The CRISPR/Cas9 system has enabled efficient modification of genes in a variety of cellular systems for studying phenotypic effects of genetic perturbations. However, with this technology comes the inherent risk of generating off-target effects (OTEs) in addition to the desired modifications. As such, it can be difficult to conclusively determine that the observed phenotypic changes are in fact due to the intended modification of the target gene and not from random mutations elsewhere in the genome. In addition, biological variations observed within cultured cells or laboratory animals can also confound results and need to be addressed. In this article, we review potential sources of experimental and biological variation as well as propose experimental options to minimize and control OTEs and other variations in CRISPR genome editing experiments for exploratory research applications. Confirmation of on-target KO effect by orthogonal approaches is also discussed.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell engineering; Clonal variations; Gene targeting; Genetic modifications; Indels; Target specificity

Mesh:

Substances:

Year:  2018        PMID: 30142414     DOI: 10.1016/j.jbiotec.2018.08.007

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  27 in total

1.  Kidney Xenotransplantation: Steps toward Clinical Application.

Authors:  Brian I Shaw; Allan D Kirk
Journal:  Clin J Am Soc Nephrol       Date:  2019-02-06       Impact factor: 8.237

2.  CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy.

Authors:  January Salas-Mckee; Weimin Kong; Whitney L Gladney; Julie K Jadlowsky; Gabriela Plesa; Megan M Davis; Joseph A Fraietta
Journal:  Hum Vaccin Immunother       Date:  2019-04-02       Impact factor: 3.452

3.  A competitive precision CRISPR method to identify the fitness effects of transcription factor binding sites.

Authors:  Päivi Pihlajamaa; Otto Kauko; Biswajyoti Sahu; Teemu Kivioja; Jussi Taipale
Journal:  Nat Biotechnol       Date:  2022-09-26       Impact factor: 68.164

Review 4.  HIV cure strategies: which ones are appropriate for Africa?

Authors:  Christopher Zaab-Yen Abana; Helena Lamptey; Evelyn Y Bonney; George B Kyei
Journal:  Cell Mol Life Sci       Date:  2022-07-06       Impact factor: 9.207

5.  Wild-type TP53 defined gamma-secretase inhibitor sensitivity and synergistic activity with doxorubicin in GSCs.

Authors:  Chen Zhang; Emmanuel Martinez-Ledesma; Feng Gao; Wei Zhang; Jie Ding; Shaofang Wu; Xiaolong Li; Jimin Wu; Ying Yuan; Dimpy Koul; W K Alfred Yung
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

6.  Control of gene doping in human and horse sports.

Authors:  Teruaki Tozaki; Natasha A Hamilton
Journal:  Gene Ther       Date:  2021-06-07       Impact factor: 5.250

Review 7.  Small nucleic acids and the path to the clinic for anti-CRISPR.

Authors:  Christopher L Barkau; Daniel O'Reilly; Seth B Eddington; Masad J Damha; Keith T Gagnon
Journal:  Biochem Pharmacol       Date:  2021-02-27       Impact factor: 6.100

Review 8.  Non-coding RNAs in cancer: platforms and strategies for investigating the genomic "dark matter".

Authors:  Katia Grillone; Caterina Riillo; Francesca Scionti; Roberta Rocca; Giuseppe Tradigo; Pietro Hiram Guzzi; Stefano Alcaro; Maria Teresa Di Martino; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  J Exp Clin Cancer Res       Date:  2020-06-20

Review 9.  Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy.

Authors:  Qiaoqiao Xiao; Deyin Guo; Shuliang Chen
Journal:  Front Cell Infect Microbiol       Date:  2019-03-22       Impact factor: 5.293

10.  Engineering a far-red light-activated split-Cas9 system for remote-controlled genome editing of internal organs and tumors.

Authors:  Yuanhuan Yu; Xin Wu; Ningzi Guan; Jiawei Shao; Huiying Li; Yuxuan Chen; Yuan Ping; Dali Li; Haifeng Ye
Journal:  Sci Adv       Date:  2020-07-10       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.